SR-3745A

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSR-3745A
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtivesSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-directed DNA polymerase inhibitors
TargetsDNA-directed DNA polymerase
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSri International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSri International
Active IndicationsN/A
Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A